PURPOSE: To examine the role of DNA repair and altered thymidine analogues in altering the response to radiation during thymidine deprivation. METHODS AND MATERIALS: Mismatch repair-deficient and -proficient cell lines HEC59 and HC-2.4 were treated with fluorodeoxyuridine (FUdR), azidothymidine (AZT), and irradiation either alone or in combination, and outcomes of clonogenic survival and cell-cycle distributions were determined. RESULTS: Survival outcomes for all treatments were similar for both cell lines, suggesting that hMSH2 does not significantly influence thymidine deprivation toxicity or radiosensitization. The chain-terminating thymidine analogue AZT increased the toxicity of FUdR and increased DNA fragmentation. The combination of FUdR and AZT afforded greater radiosensitization than either drug alone. Drug enhancement ratios, the degree of excess radiation-induced cell death in drug-treated cultures compared with radiation alone for HEC59, were 1.2, 1.4, and 1.8 for AZT, FUdR, and the combination, respectively. Enhancement ratios for HC-2.4 were 1.3, 1.5, and 1.8 for AZT, FUdR, and the combination, respectively. CONCLUSION: Azidothymidine, a chain-terminating thymidine analogue, can enhance the radiosensitizing affects of thymidine deprivation. Deoxyribonucleic acid strand breaks may play an important role in the mechanism of thymidine deprivation-induced radiosensitization. Copyright (c) 2010 Elsevier Inc. All rights reserved.
PURPOSE: To examine the role of DNA repair and altered thymidine analogues in altering the response to radiation during thymidine deprivation. METHODS AND MATERIALS: Mismatch repair-deficient and -proficient cell lines HEC59 and HC-2.4 were treated with fluorodeoxyuridine (FUdR), azidothymidine (AZT), and irradiation either alone or in combination, and outcomes of clonogenic survival and cell-cycle distributions were determined. RESULTS: Survival outcomes for all treatments were similar for both cell lines, suggesting that hMSH2 does not significantly influence thymidinedeprivation toxicity or radiosensitization. The chain-terminating thymidine analogue AZT increased the toxicity of FUdR and increased DNA fragmentation. The combination of FUdR and AZT afforded greater radiosensitization than either drug alone. Drug enhancement ratios, the degree of excess radiation-induced cell death in drug-treated cultures compared with radiation alone for HEC59, were 1.2, 1.4, and 1.8 for AZT, FUdR, and the combination, respectively. Enhancement ratios for HC-2.4 were 1.3, 1.5, and 1.8 for AZT, FUdR, and the combination, respectively. CONCLUSION:Azidothymidine, a chain-terminating thymidine analogue, can enhance the radiosensitizing affects of thymidine deprivation. Deoxyribonucleic acid strand breaks may play an important role in the mechanism of thymidine deprivation-induced radiosensitization. Copyright (c) 2010 Elsevier Inc. All rights reserved.
Authors: A Umar; M Koi; J I Risinger; W E Glaab; K R Tindall; R D Kolodner; C R Boland; J C Barrett; T A Kunkel Journal: Cancer Res Date: 1997-09-15 Impact factor: 12.701
Authors: P M Hwang; F Bunz; J Yu; C Rago; T A Chan; M P Murphy; G F Kelso; R A Smith; K W Kinzler; B Vogelstein Journal: Nat Med Date: 2001-10 Impact factor: 53.440
Authors: M Andreuccetti; G Allegrini; A Antonuzzo; G Malvaldi; P F Conte; R Danesi; M Del Tacca; A Falcone Journal: Eur J Cancer Date: 1996-06 Impact factor: 9.162
Authors: A Falcone; M Lencioni; I Brunetti; E Pfanner; G Allegrini; A Antonuzzo; M Andreuccetti; G Malvaldi; R Danesi; M Del Tacca; P F Conte Journal: Ann Oncol Date: 1997-06 Impact factor: 32.976
Authors: Yuji Seo; Michael T Kinsella; Harry L Reynolds; Gregory Chipman; Scot C Remick; Timothy J Kinsella Journal: Int J Radiat Oncol Biol Phys Date: 2009-02-07 Impact factor: 7.038